These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate. Maherault AC; Nordmann P; Therby A; Pangon B Clin Infect Dis; 2012 Feb; 54(4):577-8. PubMed ID: 22157173 [No Abstract] [Full Text] [Related]
4. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Paterson DL; Ko WC; Von Gottberg A; Mohapatra S; Casellas JM; Goossens H; Mulazimoglu L; Trenholme G; Klugman KP; Bonomo RA; Rice LB; Wagener MM; McCormack JG; Yu VL Clin Infect Dis; 2004 Jul; 39(1):31-7. PubMed ID: 15206050 [TBL] [Abstract][Full Text] [Related]
5. Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin. Endimiani A; Luzzaro F; Perilli M; Lombardi G; Colì A; Tamborini A; Amicosante G; Toniolo A Clin Infect Dis; 2004 Jan; 38(2):243-51. PubMed ID: 14699457 [TBL] [Abstract][Full Text] [Related]
6. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia. Song W; Moland ES; Hanson ND; Lewis JS; Jorgensen JH; Thomson KS J Clin Microbiol; 2005 Sep; 43(9):4891-4. PubMed ID: 16145169 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital. Souli M; Kontopidou FV; Papadomichelakis E; Galani I; Armaganidis A; Giamarellou H Clin Infect Dis; 2008 Mar; 46(6):847-54. PubMed ID: 18269335 [TBL] [Abstract][Full Text] [Related]
8. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793 [TBL] [Abstract][Full Text] [Related]
9. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India. Roy S; Viswanathan R; Singh AK; Das P; Basu S J Antimicrob Chemother; 2011 Jun; 66(6):1411-3. PubMed ID: 21393155 [No Abstract] [Full Text] [Related]
12. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone. Cobo J; Morosini MI; Pintado V; Tato M; Samaranch N; Baquero F; Cantón R Diagn Microbiol Infect Dis; 2008 Mar; 60(3):319-22. PubMed ID: 17996417 [TBL] [Abstract][Full Text] [Related]
14. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae. Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600 [TBL] [Abstract][Full Text] [Related]
15. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Nguyen M; Eschenauer GA; Bryan M; O'Neil K; Furuya EY; Della-Latta P; Kubin CJ Diagn Microbiol Infect Dis; 2010 Jun; 67(2):180-4. PubMed ID: 20356699 [TBL] [Abstract][Full Text] [Related]
16. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae. Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086 [TBL] [Abstract][Full Text] [Related]
17. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975 [TBL] [Abstract][Full Text] [Related]
18. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Nadkarni AS; Schliep T; Khan L; Zeana CB Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638 [TBL] [Abstract][Full Text] [Related]
19. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain. Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908 [TBL] [Abstract][Full Text] [Related]
20. Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Gomez-Simmonds A; Nelson B; Eiras DP; Loo A; Jenkins SG; Whittier S; Calfee DP; Satlin MJ; Kubin CJ; Furuya EY Antimicrob Agents Chemother; 2016 Jun; 60(6):3601-7. PubMed ID: 27044555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]